Early use of intravenous methylprednisolone is associated with attenuation of drug challenge reactions in patients with severe cutaneous adverse drug reactions.
- DOI
- 10.1016/j.jaip.2026.09.003
- Published
- 2026 Sep 17
- Container
- The journal of allergy and clinical immunology. In practice
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaip.2026.09.003,
title = {Early use of intravenous methylprednisolone is associated with attenuation of drug challenge reactions in patients with severe cutaneous adverse drug reactions.},
author = {Thwala B and Zitha E and Selim R and Teixeira N and Pirjol L and Porter M and Peter J and Lehloenya R},
year = {2026},
journal = {The journal of allergy and clinical immunology. In practice},
doi = {10.1016/j.jaip.2026.09.003},
url = {https://doi.org/10.1016/j.jaip.2026.09.003}
}RIS
TY - JOUR TI - Early use of intravenous methylprednisolone is associated with attenuation of drug challenge reactions in patients with severe cutaneous adverse drug reactions. AU - Thwala B AU - Zitha E AU - Selim R AU - Teixeira N AU - Pirjol L AU - Porter M AU - Peter J AU - Lehloenya R PY - 2026 JO - The journal of allergy and clinical immunology. In practice DO - 10.1016/j.jaip.2026.09.003 UR - https://doi.org/10.1016/j.jaip.2026.09.003 ER -
APA
B, T., E, Z., R, S., N, T., L, P., M, P., J, P., & R, L. (2026). Early use of intravenous methylprednisolone is associated with attenuation of drug challenge reactions in patients with severe cutaneous adverse drug reactions.. The journal of allergy and clinical immunology. In practice. https://doi.org/10.1016/j.jaip.2026.09.003
Source records
- pubmed · retrieved 2026-09-26T22:56:00.716Z